Vida Strategic Communications

Vision. Visibility. Value.

Vida Strategic Partners is an advisory firm supporting the financial, operational and communications goals of life science and healthcare companies.

About Vida Strategic Partners

Vida Strategic Partners is an advisory firm supporting the financial, operational and communications goals of life science and healthcare companies. Vida was founded in 2002 and for more than twenty years has provided senior-level counsel and executed numerous successful strategies for our clients in the following areas:

Communications Advisory:

Do you have the attention of your target audiences? If not, perhaps it is time to rethink how you communicate. Vida provides strategic public relations, investor relations and corporate communications. At our core is the considerable industry, media and Wall Street experience required to deliver results. Our singular focus on life science and healthcare keeps us close to the issues, strategies and tactics required to successfully represent our clients. Our relationships with industry leaders, media and investors allow us to provide exceptional visibility to differentiate today's leading companies, products and programs.

Business Advisory

With the experience and expertise to successfully navigate complex financial markets and the competitive business landscape, Vida provides financial strategy and corporate development support. Our founding team possesses executive-level operational experience with multiple life science and healthcare companies, as well as within industry leading agencies that provide specialized services to this sector. Given this background, the Vida team is uniquely qualified to address the strategic issues facing our clients and to partner with management teams to facilitate optimal solutions.

Regardless of the stage of your company or the complexity of your needs, we will provide the benefit of our considerable experience and work with your team to achieve your corporate objectives.

Communications

Public Relations

Which are your primary audiences? Media? Industry peers? Potential partners? Do you have their attention? If not, perhaps it’s time to rethink the way you communicate.

Whether you’re initiating a public relations program for the first time or expanding your existing PR activities, Vida has the experience and expertise to help. With a broad range of services, Vida is prepared to develop and execute a strategic public relations program to achieve your company’s specific objectives.

Message development/corporate positioning
Press and collateral materials development
Corporate/media auditing
Media backgrounding
Press release strategy, development and distribution
Media outreach in support of news announcements
Pursuit of opportunistic media
Ongoing media relations
Speaker presentation/media training
Scientific/medical conference support
Industry/competitor auditing/monitoring
Crisis management

Investor Relations

Vida offers one of the industry’s most comprehensive investor relations programs.

The core of Vida’s IR expertise is a strong foundation in key disciplines including: biopharma financial operations, analyst/investor relationships, corporate disclosure, and financial market positioning. We leverage this specialized experience daily on behalf of our clients to improve corporate visibility with the investment community and maximize shareholder value.

Analyst targeting (buy- and sell-side)
Non-deal roadshows
Support public and private financing activities
KOL, investor and analyst briefings/receptions/events
Corporate positioning (investment thesis development)
Ongoing analysis of shareholder base
Financial community audits
Competitive analysis/peer company evaluations
Business development/corporate alliance strategy and communications
Support of sell-side analyst coverage
Financial conference support
Investor presentation development
Scientific/medical conference support
Ongoing financial community outreach

Corporate Communications

With more than 60 years of industry experience, Vida has the experience and know-how to successfully craft a compelling “story” for your company’s unique assets that will best resonate with your target audiences.

Equally important is our ability to translate that story into the critical communications tools that will best reach your preferred contacts. We work with our clients on the creation and optimization of a comprehensive communication toolbox that includes websites, corporate presentations, collateral materials, graphics, animations, and videos, etc. We will then leverage those tools across a broad range of targeted communication opportunities that include investor relations, media outreach, scientific and industry conferences, third-party relations, public awareness campaigns and patient/physician education, among others. Whatever your corporate communication needs, Vida has the expertise to optimize your visibility.

Product positioning
Market/competitive analysis
Collateral material development
Website creation
Corporate presentation development
Scientific graphic design including animation and medical illustration
Corporate video creation
Medical/scientific/industry conference support
Publication support
Coalition building/third-party relationships
Physician targeting and education
Patient outreach and education
Public awareness campaigns
Events-oriented marketing

Business advisory

The financial markets that once reliably supported emerging and exciting advancements in life science and healthcare are largely unpredictable today. For this reason, development stage companies must embrace a new, more aggressive path to success and sustainable growth.

Since 2002, Vida has been dedicated to advising and supporting biotechnology and life science companies as they navigate complex financial markets and the competitive business landscape. At the cornerstone of Vida’s practice is our considerable operational experience. Having served as a senior executive with a number of biotechnology and life science companies, Stephanie Diaz has executed numerous public and private financings, directed finance and accounting functions, managed business development efforts, worked with manufacturing and marketing teams to initiate production and commercialization of new products, and executed public and investor relations programs.

Today, Vida is putting this experience to work for our clients, customizing strategies to match the specific needs of each company. We have worked on both ends of the spectrum, aiding small companies to envision and execute innovative financing strategies. We have also supported multinational corporations in their efforts to maintain global leadership through partnership. Regardless of the size or situation, Vida offers the innovative thinking and experience required to develop and execute your strategy for success.

Financing strategy
Corporate development

Team

Stephanie C. Diaz

President and CEO

Ms. Diaz has worked in the biotechnology/life science industry for more than 30 years and founded Vida Strategic Partners in September 2002. Prior to founding Vida, Ms. Diaz served as senior vice president and director, for Burns McClellan, a national healthcare communications agency. In this role, Ms. Diaz had responsibility for heading all Burns McClellan West Coast operations.

Prior to joining Burns McClellan, Ms. Diaz held a number of senior financial positions with several biotechnology and life science companies, serving as vice president and chief financial officer of Shaman Pharmaceuticals, Inc., director of finance of Hyseq, Inc. (renamed Nuvelo, Inc.), and director of finance of Martek Biosciences Corporation. During her career, Ms. Diaz has managed finance and accounting functions, directed public and private financings, managed business development efforts, worked with manufacturing and marketing teams, and supervised public and investor relations programs.

Ms. Diaz serves as an advisor for California Life Sciences (CLS), through which she has mentored some of the Bay Area’s most promising life science start-up companies including: Pendulum Therapeutics, Ciel Medical, Correlia Biosystems, EpiBiome, Paragon Genomics and Trellis Biosciences. Previously, Ms. Diaz was a member of the board of directors of Palisade Bio, Inc., serving on audit and finance committees, and chairing the nomination and governance committee.

Ms. Diaz earned a master of business administration with a focus in finance from Georgetown University and a bachelor of arts degree in international relations from Stanford University.

Significant experience in biotechnology/life science finance and communications
Focus on investor relations, financing strategy and corporate/business development
Significant biotech/life science operations experience including:
- Fundraising (private and public financings)
- Finance and accounting
- Corporate/business development
Communications expertise in the following areas:
- Supporting stock value through targeted investor outreach
- Strategic positioning
- Financial community events and communications

Jennifer L. Arcure

Senior Vice President

Ms. Arcure is a senior strategy and communications leader with nearly three decades of experience in the biotechnology, pharmaceutical, and healthcare industries. She has built her career at the intersection of corporate strategy, executive communications, and public relations, supporting C-suite leaders across Fortune 50 companies and emerging biotech organizations.

Prior to joining Vida Strategic Partners in April 2026, Ms. Arcure held senior leadership roles at leading healthcare communications firms, including serving as senior vice president at GCI Health and Inizio (formerly Canale Communications). In these roles, she directed corporate and product communications for biotechnology and pharmaceutical companies, advising executive teams on strategic positioning, data, regulatory milestone communications, media relations, and thought leadership. She has led multimillion-dollar communication programs, driven business growth, and helped organizations navigate complex inflection points, including clinical milestones and reputation challenges. Before Inizio, Ms. Arcure was a senior director at Verge Scientific Communications, where she oversaw client portfolios, led cross-functional teams, and developed strategic communications for venture-backed biotech firms. Her work focused on building corporate narratives, preparing companies for launches, and amplifying visibility through integrated media and digital campaigns.

Ms. Arcure also served as chief of staff to the CEO of the Juvenile Diabetes Research Foundation (JDRF), where she managed executive communications, strategic planning, and board engagement, and supported major organizational and fundraising initiatives.
She began her career at Pfizer Inc., where she spent over a decade in leadership positions focused on strategic planning and executive communications. During this time, she assisted the company’s C-suite with key initiatives, including product launches, M&A activities, and corporate strategy. She also managed executive communications for the global pharmaceutical division, including external messaging and speechwriting, and provided critical insights to guide decisions and drive business results.

Ms. Arcure earned a master of business administration and a bachelor of arts in political science from the University of Michigan.

Extensive experience in biotechnology, pharmaceutical, and healthcare corporate communications and strategy.
Focus on corporate positioning, executive communications, strategic narrative development, and media relations.
Significant life sciences communications experience including:
- Corporate and product communications strategy
- Data, regulatory, and clinical milestone communications
- Executive communications, including speechwriting and external visibility
- Issues management and reputation strategy
- Media relations and thought leadership development
Communications expertise in the following areas:
- Company positioning and corporate narrative development
- Translating complex scientific and business strategies into clear, compelling storylines
- Building integrated communications programs across media, digital, and internal channels
- Creating and implementing strategies for thought leadership and enhancing executive visibility.
- Positioning companies at key inflection points, including clinical milestones, financings, and other corporate milestones